Semaglutide Weight Management and Cardiovascular Risk Reduction
Investor contact information
Share information
Novo Nordisk's B shares are listed on the stock exchange in Copenhagen
under the symbol 'NOVO B'. Its ADRs are listed on the New York Stock
Exchange under the symbol 'NVO'.
For further company information, visit Novo Nordisk on:
www.novonordisk.com
Novo Nordisk A/S
Investor Relations
Novo Alle 1
DK-2880 Bagsværd
Investor Relations contacts
Daniel Muusmann Bohsen
David Heiberg Landsted
Jacob Martin Wiborg Rode
Mark Joseph Root (USA)
+45 3075 2175
+45 3077 6915
+45 3075 5956
+1 848 213 3219
[email protected]
[email protected]
[email protected]
[email protected]
10 August 2023
Upcoming events
Financial statement for the first six months of 2023
02 November 2023 Financial statement for the first nine months of 2023
31 January 2024
Financial statement 2023View entire presentation